BEN vs TERN · P/E 36, rev $8.77B vs $6.12B cap
Franklin Resources Inc (BEN) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
BEN currently screens at market cap $13.09B and trailing P/E 35.6. TERN currently screens at market cap $6.12B.
Not investment advice. Open the BEN and TERN stock pages for the full models.
Not investment advice.